An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.

An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
复制标题

DOI:
10.1016/j.antiviral.2017.08.005
复制
发表时间:
2017-10
期刊:
影响因子:
7.6
通讯作者:
Mühlberger E
Mühlberger E
中科院分区:
医学2区
文献类型:
--
作者:
Nelson EV;Pacheco JR;Hume AJ;Cressey TN;Deflubé LR;Ruedas JB;Connor JH;Ebihara H;Mühlberger E

文献摘要

参考文献

被引文献

相似文献

Ebola virus (EBOV) causes a severe disease in humans with the potential for significant international public health consequences. Currently, treatments are limited to experimental vaccines and therapeutics. Therefore, research into prophylaxis and antiviral strategies to combat EBOV infections is of utmost importance. The requirement for high containment laboratories to study EBOV infection is a limiting factor for conducting EBOV research. To overcome this issue, minigenome systems have been used as valuable tools to study EBOV replication and transcription mechanisms and to screen for antiviral compounds at biosafety level 2. The most commonly used EBOV minigenome system relies on the ectopic expression of the T7 RNA polymerase (T7), which can be limiting for certain cell types. We have established an improved EBOV minigenome system that utilizes endogenous RNA polymerase II (pol II) as a driver for the synthesis of minigenome RNA. We show here that this system is as efficient as the T7-based minigenome system, but works in a wider range of cell types, including biologically relevant cell types such as bat cells. Importantly, we were also able to adapt this system to a reliable and cost-effective 96-well format antiviral screening assay with a Z-factor of 0.74, indicative of a robust assay. Using this format, we identified JG40, an inhibitor of Hsp70, as an inhibitor of EBOV replication, highlighting the potential for this system as a tool for antiviral drug screening. In summary, this updated EBOV minigenome system provides a convenient and effective means of advancing the field of EBOV research.
DOI: 10.1021/acs.jproteome.6b00337
发表时间: 2016-12-01
影响因子: 4.4
作者:
Garcia-Dorival, Isabel;Wu, Weining;Hiscox, Julian A.
通讯作者: Hiscox, Julian A.
DOI: 10.1128/jvi.01863-14
发表时间: 2014-11-01
影响因子: 5.4
作者:
Brauburger, Kristina;Boehmann, Yannik;Muehlberger, Elke
通讯作者: Muehlberger, Elke
DOI: 10.1128/jvi.79.7.4425-4433.2005
发表时间: 2005-04-01
影响因子: 5.4
作者:
Groseth, A;Feldmann, H;Flick, R
通讯作者: Flick, R
DOI: 10.1128/jvi.68.2.713-719.1994
发表时间: 1994-02-01
影响因子: 5.4
作者:
CONZELMANN, KK;SCHNELL, M
通讯作者: SCHNELL, M